Prednisone can temporarily reduce psoriasis symptoms, but dermatologists almost universally advise against using it for this condition. The short-term relief comes at a steep cost: when you stop taking prednisone, psoriasis frequently rebounds worse than before, and in rare cases it can trigger a dangerous form of the disease called generalized pustular psoriasis. For these reasons, oral steroids are not a recommended treatment for psoriasis and should only be used in exceptional circumstances.
How Prednisone Affects Psoriasis Symptoms
Prednisone is a glucocorticoid, a type of steroid that suppresses the immune system and reduces inflammation. In psoriasis, the immune system drives skin cells to multiply far too quickly, creating thick, scaly plaques. Prednisone works by entering cells and blocking the production of inflammatory molecules like prostaglandins, leukotrienes, and key signaling proteins that fuel this cycle. It also slows cell division in the skin and reduces the activity of immune cells that congregate in psoriatic plaques.
These are powerful effects, and they explain why someone taking prednisone for another condition (a severe allergic reaction, for instance) might notice their psoriasis clearing up. The problem is what happens next.
The Rebound Effect
Psoriasis is a chronic immune-mediated disease. Prednisone doesn’t change the underlying immune dysfunction; it just suppresses it temporarily. When the drug is tapered or stopped, the immune system rebounds, often with more intensity than before. Plaques can return rapidly and spread to areas that were previously unaffected.
In more serious cases, stopping oral steroids can convert stable plaque psoriasis into generalized pustular psoriasis, a potentially life-threatening form of the disease where painful, pus-filled blisters erupt across large areas of skin. Case reports describe patients who developed this complication specifically during prednisone dose reductions, even when the tapering was done gradually. One published case involved a 70-year-old woman who worsened so dramatically during a prednisone taper that she abandoned treatment and sought emergency care. Systemic steroid use and subsequent withdrawal is considered one of the most well-known triggers for this dangerous flare.
Why Doctors Still Sometimes Prescribe It
There are rare situations where prednisone ends up being used in someone with psoriasis, usually to treat a completely different condition. A case published in the Cleveland Clinic Journal of Medicine described a 69-year-old man with well-controlled plaque psoriasis who needed prednisone for a painful joint condition called calcium pyrophosphate deposition disease. He had failed or had contraindications to every other treatment option. The prednisone controlled his joint pain, but practitioners had to weigh that benefit against the risk of triggering a severe psoriasis flare.
These decisions are made on a case-by-case basis when no safer alternative exists. They are not standard psoriasis care.
Prednisone for Psoriatic Arthritis
Psoriatic arthritis is one area where low-dose steroids occasionally play a limited, carefully monitored role. Joint pain and swelling from psoriatic arthritis can be severe enough to interfere with daily life, and some patients get meaningful relief from small doses of prednisolone (a closely related steroid) combined with other medications.
In case studies, adding just 10 mg of prednisolone on alternate days to methotrexate controlled joint symptoms within a week and allowed patients to stop taking anti-inflammatory painkillers entirely. The key distinction is that the steroid was used at a low dose, on a specific schedule, alongside a disease-modifying drug that addressed the underlying condition. Using oral steroids alone for psoriatic arthritis is discouraged because it doesn’t prevent long-term joint damage and carries the same rebound risks for skin symptoms.
Topical Steroids Are a Different Story
It’s worth separating oral prednisone from topical corticosteroids, which are creams and ointments applied directly to psoriasis plaques. Topical steroids are a first-line treatment for psoriasis of all severities and work through the same anti-inflammatory and cell-slowing mechanisms. Because they act locally on the skin rather than throughout the entire body, they carry far fewer systemic risks.
That said, long-term heavy use of topical steroids isn’t risk-free either. Research on psoriasis patients using topical corticosteroids long-term found that exceeding about 50 grams per week increased the risk of adrenal insufficiency (where the body’s own cortisol production shuts down), Cushing’s syndrome, and osteoporosis. These are the same complications associated with oral prednisone, just at a lower rate. Your dermatologist will typically rotate topical steroids with non-steroidal treatments to minimize these risks.
Safer Alternatives for Moderate to Severe Psoriasis
If your psoriasis is severe enough that you’re wondering about oral steroids, there are systemic treatments specifically designed for long-term use that don’t carry the rebound risk. The typical starting options include methotrexate, fumaric acid esters, and cyclosporine, all of which target the overactive immune response driving the disease.
If those don’t provide enough relief, a newer class of drugs called biologics has transformed psoriasis care over the past two decades. Biologics work by blocking specific immune signaling molecules involved in psoriasis rather than suppressing the entire immune system the way prednisone does. Options include drugs that target tumor necrosis factor, interleukin-17, interleukin-23, and interleukin-12/23. Many patients on biologics achieve 75% to 90% skin clearance, and some reach completely clear skin.
Another option is apremilast, an oral medication that reduces inflammation through a different pathway than steroids and doesn’t require the same level of lab monitoring as methotrexate or cyclosporine. Treatment with biologics is usually considered for people who haven’t responded well enough to UV light therapy or first-line systemic medications.
All of these carry their own side effects and tradeoffs, but none of them cause the characteristic rebound flare that makes prednisone so problematic for psoriasis. If you’re currently managing psoriasis with topical treatments alone and feel like your disease isn’t controlled, these systemic options are worth discussing rather than reaching for oral steroids.